4.9M MOLECULAR TESTS PERFORMED AS OF SEPTEMBER 1
48 STATES SENDING COVID-19 TESTING TO MAYO CLINIC
3 WEEKS IT TOOK MAYO TO DEVELOP A PCR LDT
Useful for detection of COVID-19 due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Useful for the detection and quantification of severe respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19); useful for serial monitoring of SARS-CoV-2 RNA concentrations in the upper respiratory tract of individuals receiving antiviral or immune therapy. For more information, contact us.
Useful for detection of IgG-class antibodies against SARS-CoV-2, the virus that causes COVID-19.
Useful for aiding the identification of individuals with an adaptive immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), indicating recent or prior infection. For more information, contact us.